INTERVENTIONS FOR IMPROVING OUTCOMES OF CHILDREN WHO ARE DEAF OR HARD OF HEARING
Professor Teresa Y C Ching
Professorial Fellow, NextSense Institute, Sydney;
Conjoint Professor, Macquarie University, Sydney;
Honorary Professor, University of Queensland, Brisbane, Australia
RESEARCHER PROFILE
Filmed in Sydney | June 2025
About two to six per thousand children have a hearing loss that prevents them from achieving their full potential in life. They experience many more difficulties in cognitive, language and social development than their hearing peers. We know that early detection through newborn hearing screening is crucial, but less is known about how intervention can best be targeted to meet the needs of individual children and their families.
Professor Teresa Ching has led population-based studies that drive evidence-based practice in intervention for improving outcomes of children who are deaf or hard of hearing. Much of her research findings have been translated into practice and policy. However, many children from culturally and linguistically diverse backgrounds remain vulnerable, requiring intervention tailored to their needs. Furthermore, many children have undetected, untreated hearing problems when they enter school, thereby reducing their educational attainment and social participation.
Teresa is a Conjoint Professor at NextSense Institute and Macquarie University, and an Honorary Professor at the University of Queensland in Australia. Her current research focuses on devising culturally sensitive practices in early detection and intervention to maximise children’s outcomes. Working with international colleagues, her current research is also directed towards developing global guidelines and recommendations for hearing screening beyond the newborn period, so that all children can benefit from early detection and intervention. The ultimate goal is to attain equity of care and outcomes for all children with hearing difficulties.
Source: Supplied
-
Radiation therapy techniques and combination treatments for sarcoma
Professor Angela Hong MBBS, MMed, PhD, FRANZCR is a Professor at Sydney Medical School of the University of Sydney. She is a radiation oncologist and has been a member of the Multidisciplinary Bone and Soft Tissue Tumour Clinic at Royal Prince Alfred Hospital/Chris O’Brien Lifehouse for the past 15 years.
As a radiation oncologist located in Sydney, Australia, Professor Hong is focused on treating patients with bone and soft tissue sarcoma. And as a clinician scientist, her research focuses on developing innovative radiation therapy technique and combination treatments to improve the outcome for patients with sarcoma.
-
Biological interactions of extracellular vesicles
Raluca Ghebosu graduated from the University of Queensland with a Bachelor of Arts/Bachelor of Science with majors in Japanese and Biomedical Science (2018-2021). She then completed her Bachelor of Science (Honours) with the School of Biomedical Sciences at the University of Queensland in 2022, before pursuing a PhD with A/Prof. Joy Wolfram at the Australian Institute for Bioengineering and Nanotechnology.
-
Mechanisms of resistance to menin inhibitor therapy and Acute Myeloid Leukaemia
Dr Rithin Nedumannil (MBBS, MPH, FRACP, FRCPA) is a PhD candidate at the University of Melbourne, undertaking his doctoral studies in collaboration with the Cambridge Stem Cell Institute (Cambridge, UK) and the Peter MacCallum Cancer Centre (Melbourne, Australia). He is a clinical haematologist and haematopathologist with current appointments at Peter MacCallum Cancer Centre, the Royal Melbourne Hospital, Austin Health and Northern Health.
